Literature DB >> 30016264

Effect of temperature control on the metabolite content in exhaled breath condensate.

Konstantin O Zamuruyev1, Eva Borras1, Dayna R Pettit1, Alexander A Aksenov1, Jason D Simmons1, Bart C Weimer2, Michael Schivo3, Nicholas J Kenyon3, Jean-Pierre Delplanque1, Cristina E Davis4.   

Abstract

The non-invasive, quick, and safe collection of exhaled breath condensate makes it a candidate as a diagnostic matrix in personalized health monitoring devices. The lack of standardization in collection methods and sample analysis is a persistent limitation preventing its practical use. The collection method and hardware design are recognized to significantly affect the metabolomic content of EBC samples, but this has not been systematically studied. Here, we completed a series of experiments to determine the sole effect of collection temperature on the metabolomic content of EBC. Temperature is a likely parameter that can be controlled to standardize among different devices. The study considered six temperature levels covering two physical phases of the sample; liquid and solid. The use of a single device in our study allowed keeping saliva filtering and collector surface effects as constant parameters and the temperature as a controlled variable; the physiological differences were minimized by averaging samples from a group of volunteers and a period of time. After EBC collection, we used an organic solvent rinse to collect the non-water-soluble compounds from the condenser surface. This additional matrix enhanced metabolites recovery, was less dependent on temperature changes, and may possibly serve as an additional pointer to standardize EBC sampling methodologies. The collected EBC samples were analyzed with a set of mass spectrometry methods to provide an overview of the compounds and their concentrations present at each temperature level. The total number of volatile and polar non-volatile compounds slightly increased in each physical phase as the collection temperature was lowered to minimum, 0 °C for liquid and -30, -56 °C for solid. The low-polarity non-volatile compounds showed a weak dependence on the collection temperature. The metabolomic content of EBC samples may not be solely dependent on temperature but may be influenced by other phenomena such as greater sample dilution due to condensation from the ambient air at colder temperatures, or due to adhesion properties of the collector surface and occurring chemical reactions. The relative importance of other design parameters such as condenser coating versus temperature requires further investigation.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Analytical methods; Breath metabolomics; Collection temperature control; Exhaled breath condensate (EBC)

Mesh:

Year:  2017        PMID: 30016264      PMCID: PMC6050983          DOI: 10.1016/j.aca.2017.12.025

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  45 in total

1.  Hydrogen peroxide and nitric oxide in exhaled air of children with cystic fibrosis during antibiotic treatment.

Authors:  Q Jöbsis; H C Raatgeep; S L Schellekens; A Kroesbergen; W C Hop; J C de Jongste
Journal:  Eur Respir J       Date:  2000-07       Impact factor: 16.671

2.  Exhaled breath condensate pH is a robust and reproducible assay of airway acidity.

Authors:  J Vaughan; L Ngamtrakulpanit; T N Pajewski; R Turner; T A Nguyen; A Smith; P Urban; S Hom; B Gaston; J Hunt
Journal:  Eur Respir J       Date:  2003-12       Impact factor: 16.671

Review 3.  Exhaled breath condensate: an overview.

Authors:  Michael D Davis; Alison Montpetit; John Hunt
Journal:  Immunol Allergy Clin North Am       Date:  2012-07-20       Impact factor: 3.479

4.  Temperature changes in exhaled breath condensate collection devices affect observed acetone concentrations.

Authors:  Bryan R Loyola; Abhinav Bhushan; Michael Schivo; Nicholas J Kenyon; Cristina E Davis
Journal:  J Breath Res       Date:  2008-09-08       Impact factor: 3.262

5.  Targeted eicosanoids lipidomics of exhaled breath condensate in healthy subjects.

Authors:  Marek Sanak; Anna Gielicz; Krzysztof Nagraba; Marek Kaszuba; Jagoda Kumik; Andrew Szczeklik
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-07-01       Impact factor: 3.205

6.  Oxidant activity in expired breath of patients with adult respiratory distress syndrome.

Authors:  S R Baldwin; R H Simon; C M Grum; L H Ketai; L A Boxer; L J Devall
Journal:  Lancet       Date:  1986-01-04       Impact factor: 79.321

7.  Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide.

Authors:  L P Ho; J A Innes; A P Greening
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

8.  Study of exhaled breath condensate sample preparation for metabolomics analysis by LC-MS/MS in high resolution mode.

Authors:  M A Fernández-Peralbo; M Calderón Santiago; F Priego-Capote; M D Luque de Castro
Journal:  Talanta       Date:  2015-08-06       Impact factor: 6.057

9.  Influence of condensing equipment and temperature on exhaled breath condensate pH, total protein and leukotriene concentrations.

Authors:  Krisztina Czebe; Imre Barta; Balázs Antus; Márta Valyon; Ildikó Horváth; Tamás Kullmann
Journal:  Respir Med       Date:  2008-01-31       Impact factor: 3.415

10.  Comparative analysis of selected exhaled breath biomarkers obtained with two different temperature-controlled devices.

Authors:  Frank Hoffmeyer; Monika Raulf-Heimsoth; Volker Harth; Jürgen Bünger; Thomas Brüning
Journal:  BMC Pulm Med       Date:  2009-11-30       Impact factor: 3.317

View more
  1 in total

1.  Challenges in Quantifying 8-OHdG and 8-Isoprostane in Exhaled Breath Condensate.

Authors:  Maud Hemmendinger; Jean-Jacques Sauvain; Nancy B Hopf; Guillaume Suárez; Irina Guseva Canu
Journal:  Antioxidants (Basel)       Date:  2022-04-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.